...
首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Electrospun vascular grafts with improved compliance matching to native vessels
【24h】

Electrospun vascular grafts with improved compliance matching to native vessels

机译:电纺血管移植物,与天然血管的顺应性更高

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Coronary artery bypass grafting is one of the most commonly performed major surgeries in the United States. Autologous vessels such as the saphenous vein are the current gold standard for treatment; however, synthetic vascular prostheses made of expanded poly(tetrafluoroethylene) or poly(ethylene terephthalate) are used when autologous vessels are unavailable. These synthetic grafts have a high failure rate in small diameter (<4 mm) applications due to rapid reocclusion via intimal hyperplasia. Current strategies to improve clinical performance are focused on preventing intimal hyperplasia by fabricating grafts with compliance and burst pressure similar to native vessels. To this end, we have developed an electrospun vascular graft from segmented polyurethanes with tunable properties by altering material chemistry and graft microarchitecture. Relationships between polyurethane tensile properties and biomechanical properties were elucidated to select polymers with desirable properties. Graft thickness, fiber tortuosity, and fiber fusions were modulated to provide additional tools for controlling graft properties. Using a combination of these strategies, a vascular graft with compliance and burst pressure exceeding the saphenous vein autograft was fabricated (compliance=6.0 +/- 0.6%/mmHg x 10(-4), burst pressure=2260 +/- 160 mmHg). This graft is hypothesized to reduce intimal hyperplasia associated with low compliance in synthetic grafts and improve long-term clinical success. Additionally, the fundamental relationships between electrospun mesh microarchitecture and mechanical properties identified in this work can be utilized in various biomedical applications. (c) 2014 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater, 103B: 313-323, 2015.
机译:冠状动脉旁路移植术是美国最常用的大手术之一。自体血管,例如大隐静脉,是目前治疗的金标准。但是,如果无法获得自体血管,则使用由膨胀的聚四氟乙烯或聚对苯二甲酸乙二酯制成的人工合成血管。由于通过内膜增生迅速重新闭塞,这些合成移植物在小直径(<4 mm)应用中具有很高的失败率。当前改善临床表现的策略集中在通过制造具有类似于天然血管的顺应性和破裂压力的移植物来预防内膜增生。为此,我们通过改变材料的化学性质和接枝微结构,从具有可调性能的分段聚氨酯中开发出了一种电纺血管接枝。阐明了聚氨酯拉伸性能与生物力学性能之间的关系,以选择具有所需性能的聚合物。移植物的厚度,纤维的曲折度和纤维的融合被调节以提供控制移植物性能的其他工具。使用这些策略的组合,制造出顺应性和破裂压力超过大隐静脉自体移植的血管移植物(顺应性= 6.0 +/- 0.6%/ mmHg x 10(-4),破裂压力= 2260 +/- 160 mmHg) 。假设该移植物可减少与人工移植物依从性差相关的内膜增生,并提高长期临床成功率。另外,在这项工作中确定的静电纺丝微结构与机械性能之间的基本关系可以用于各种生物医学应用中。 (c)2014 Wiley Periodicals,Inc. J Biomed Mater Res B部分:Appl Biomater,103B:313-323,2015年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号